Observational studies | Infection prevention studies | |||
---|---|---|---|---|
No intervention | Non-dec | Anti-septic | TAP ± PPAP | |
All groups | ||||
Acinetobacter | ||||
CC or observational groups | 203/189338 0.11% (20) | 1/553 0.18% (2) | 17/39162 0.04% (8) | 15/1860 0.8% (13) |
Intervention groups | 1/526 0.19% (2) | 7/57009 0.01% (8) | 15/13290a 0.11% (18) | |
Pseudomonas | ||||
CC or observational groups | 567/192203 0.30% (27) | 2/553 0.36% (2) | 23/39162 0.06% (8) | 63/5280 1.2% (16) |
Intervention groups | 3/526 0.57% (2) | 52/59117 0.09% (9) | 139/23543 0.59% (25) | |
Excluding groups with LOS < 7 days | ||||
Acinetobacter | ||||
CC or observational groups | 37/12913b,c 0.29% (11) | 0/200b 0% (1) | 0/308b 0% (3) | 14/904b 1.5% (11) |
Intervention groups | 1/199c 0.5% (1) | 1/305c 0.33% (3) | 11/1256c 0.88% (14) | |
Pseudomonas | ||||
CC or observational groups | 111/14453d,e 0.77% (16) | 0/200d 0% (1) | 0/308d 0.0% (3) | 63/5249d 1.2% (15) |
Intervention groups | 2/199e 1.0% (1) | 17/2413e 0.7% (4) | 94/12531e,f 0.75% (22) |